Brain tumor susceptibility: The role of genetic factors and uses of mouse models to unravel risk

Brain Pathology

Volumn 19, Issue 1, 2009, Pages 121-131

  Reilly, Karlyne M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Astrocytoma; Genetic risk factors; Glioblastoma multiforme; Mouse models; Neurofibromatosis; Peripheral nerve sheath tumors

Indexed keywords

ALCOHOL CONSUMPTION; ANIMAL TISSUE; ASTROCYTOMA; BRAIN TUMOR; CANCER PATIENT; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; DNA POLYMORPHISM; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; GENE MAPPING; GENE MUTATION; GENE SILENCING; GENETIC HETEROGENEITY; GENOME IMPRINTING; GLIOBLASTOMA; HEREDITY; MEDULLOBLASTOMA; MORBIDITY; MOUSE; NERVE SHEATH TUMOR; NONHUMAN; OLIGODENDROGLIOMA; RADIATION EXPOSURE; RISK FACTOR; SMOKING; TUMOR MODEL;

ANIMALS; ASTROCYTOMA; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, TRANSGENIC; RISK FACTORS;

EID: 57449093204     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2008.00236.x     Document Type: Conference Paper

References (83)

1. Ahlbom A, Feychting M, Cardis E, Elliott P (2007) Re: cellular telephone use and cancer risk: update of a nationwide Danish cohort study. J Natl Cancer Inst 99 : 655 author reply -6.
2. Astrinidis A, Henske EP (2005) Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease. Oncogene 24 : 7475 7481.
3. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63 : 851 859.
4. Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE et al (1999) Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286 : 2528 2531.
5. Bethke L, Sullivan K, Webb E, Murray A, Schoemaker M, Auvinen A et al (2008) The common D302H variant of CASP8 is associated with risk of glioma. Cancer Epidemiol Biomarkers Prev 17 : 987 989.
6. Bethke L, Webb E, Murray A, Schoemaker M, Johansen C, Christensen HC et al (2008) Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet 17 : 800 805.
7. Bliskovsky V, Ramsay ES, Scott J, DuBois W, Shi W, Zhang S et al (2003) Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene. Proc Natl Acad Sci USA 100 : 14982 14987.
8. Brannan C, Perkins A, Vogel K, Ratner N, Nordlund M, Reid S et al (1994) Targeted disruption of the neurofibromatosis type 1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 8 : 1019 1029.
9. Chesler EJ, Miller DR, Branstetter LR, Galloway LD, Jackson BL, Philip VM et al (2008) The Collaborative Cross at Oak Ridge National Laboratory: developing a powerful resource for systems genetics. Mamm Genome 19 : 382 389.
10. Churchill GA, Airey DC, Allayee H, Angel JM, Attie AD, Beatty J et al (2004) The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet 36 : 1133 1137.
11. Cichowski K, Shih T, Schmitt E, Santiago S, Reilly K, McLaughlin M et al (1999) Mouse models of tumor development in neurofibromatosis type I. Science 286 : 2172 2176.
12. Cormier R, Hong K, Halberg R, Hawkins T, Richardson P, Mulherkar R et al (1997) Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet 17 : 88 91.
13. Crawford NP, Qian X, Ziogas A, Papageorge AG, Boersma BJ, Walker RC et al (2007) Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet 3 : e214.
14. Daniels SR, Greer FR (2008) Lipid screening and cardiovascular health in childhood. Pediatrics 122 : 198 208.
15. de Andrade M, Barnholtz JS, Amos CI, Adatto P, Spencer C, Bondy ML (2001) Segregation analysis of cancer in families of glioma patients. Genet Epidemiol 20 : 258 270.
16. Dietrich W, Lander E, Smith J, Moser A, Gould K, Luongo C et al (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75 : 631 639.
17. Ding H, Roncari L, Shannon P, Wu X, Lau N, Karaskova J et al (2001) Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res 61 : 3826 3836.
18. Donehower L, Harvey M, Slagle B, McArthur M, Montgomery C Jr., Butel J, Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356 : 215 221.
19. Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yuan J, Chan F et al (2003) Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet 34 : 403 412.
20. Friedman JM, Gutmann DH, MacCollin M, Riccardi VM (1999) Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 3rd edn. Johns Hopkins University Press : Baltimore.
21. Gould K, Luongo C, Moser A, McNeley M, Borenstein N, Shedlovsky A et al (1996) Genetic evaluation of candidate genes for the Mom1 modifier of intestinal neoplasia in mice. Genetics 144 : 1777 1785.
22. Gutmann D, Wood D, Collins F (1991) Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci USA 88 : 9658 9662.
23. Hallahan AR, Pritchard JI, Hansen S, Benson M, Stoeck J, Hatton BA et al (2004) The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res 64 : 7794 7800.
24. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM et al (1995) The molecular basis of Turcot's syndrome. N Engl J Med 332 : 839 847.
25. Hardell L, Carlberg M, Soderqvist F, Hansson Mild K (2008) Meta-analysis of long-term mobile phone use and the association with brain tumours. Int J Oncol 32 : 1097 1103.
26. Hattori S, Maekawa M, Nakamura S (1992) Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21. Oncogene 7 : 481 485.
27. Hawes JJ, Tuskan RG, Reilly KM (2007) Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies. Neurogenetics 8 : 121 130.
28. Hunter KW, Crawford NP (2008) The future of QTL mapping to diagnose disease in mice in the age of whole-genome association studies. Annu Rev Genet Epub ahead of print S, Hughes R (1994) The Neurofibromatoses: A pathogenetic and Clinical Overview. Chapman & Hall Medical : London.
29. Iraqi FA, Churchill G, Mott R (2008) The Collaborative Cross, developing a resource for mammalian systems genetics: a status report of the Wellcome Trust cohort. Mamm Genome 19 : 379 381.
30. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA (1994) Tumor spectrum analysis in p53-mutant mice. Current Biology 4 : 1 7.
31. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA (1994) Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 7 : 353 361.
32. Jefferson T (1787) Notes on the State of Virginia. Available at: http://etext.lib.virginia.edu/modeng/modengJ.browse.html (accessed September 22, 2008).
33. Kan P, Simonsen SE, Lyon JL, Kestle JR (2008) Cellular phone use and brain tumor: a meta-analysis. J Neurooncol 86 : 71 78.
34. Kiuru A, Lindholm C, Heinavaara S, Ilus T, Jokinen P, Haapasalo H et al (2008) XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol 88 : 135 142.
35. Kwiatkowski DJ, Manning BD (2005) Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 14 Spec No. 2 : R251 258.
36. Lai R, Crevier L, Thabane L (2005) Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev 14 : 1784 1790.
37. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J et al (2001) Initial sequencing and analysis of the human genome. Nature 409 : 860 921.
38. Lindblad-Toh K, Winchester E, Daly MJ, Wang DG, Hirschhorn JN, Laviolette JP et al (2000) Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse. Nat Genet 24 : 381 386.
39. Malkin D (1994) p53 and the Li-Fraumeni syndrome. Biochim Biophys Acta 1198 : 197 213.
40. Malmer B, Iselius L, Holmberg E, Collins A, Henriksson R, Gronberg H (2001) Genetic epidemiology of glioma. Br J Cancer 84 : 429 434.
41. Malmer B, Henriksson R, Gronberg H (2003) Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer 106 : 260 263.
42. Malmer B, Feychting M, Lonn S, Ahlbom A, Henriksson R (2005) p53 Genotypes and risk of glioma and meningioma. Cancer Epidemiol Biomarkers Prev 14 : 2220 2223.
43. Malmer B, Haraldsson S, Einarsdottir E, Lindgren P, Holmberg D (2005) Homozygosity mapping of familial glioma in Northern Sweden. Acta Oncol 44 : 114 119.
44. Malmer B, Adatto P, Armstrong G, Barnholtz-Sloan J, Bernstein JL, Claus E et al (2007) GLIOGENE an International Consortium to Understand Familial Glioma. Cancer Epidemiol Biomarkers Prev 16 : 1730 1734.
45. Malmer BS, Feychting M, Lonn S, Lindstrom S, Gronberg H, Ahlbom A et al (2007) Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J Neurooncol 82 : 229 237.
46. Martin G, Viskochil D, Bollag G, McCabe P, Crosier W, Conroy L et al (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63 : 843 849.
47. McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, Mastrogianakis M et al (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature [Epub ahead of print G, Balmer L, Monley D (2008) Establishment of "The Gene Mine": a resource for rapid identification of complex trait genes. Mamm Genome 19 : 390 393.
48. Mural RJ, Adams MD, Myers EW, Smith HO, Miklos GL, Wides R et al (2002) A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science 296 : 1661 1671.
49. Muscat JE, Hinsvark M, Malkin M (2006) Mobile telephones and rates of brain cancer. Neuroepidemiology 27 : 55 56.
50. Nadeau JH, Singer JB, Matin A, Lander ES (2000) Analysing complex genetic traits with chromosome substitution strains published erratum appears in Nat Genet 2000 May Nat Genet 24 : 221 225.
51. O'Neill BP, Blondal H, Yang P, Olafsdottir GH, Sigvaldason H, Jenkins RB et al (2002) Risk of cancer among relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev 11 : 921 924.
52. Okcu MF, Selvan M, Wang LE, Stout L, Erana R, Airewele G et al (2004) Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res 10 : 2618 2625.
53. Park YG, Zhao X, Lesueur F, Lowy DR, Lancaster M, Pharoah P et al (2005) Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat Genet 37 : 1055 1062.
54. Parker-Pope T (2008) Cholesterol screening is urged for young. New York Times. Available at: http://query.nytimes.com/gst/fullpage.html?res= 9503E4DD133FF934A35754C0A96E9C8B63.
55. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321 : 1807 1812.
56. Paunu N, Lahermo P, Onkamo P, Ollikainen V, Rantala I, Helen P et al (2002) A novel low-penetrance locus for familial glioma at 15q23-q26.3. Cancer Res 62 : 3798 3802.
57. Pennisi E (2007) Breakthrough of the year. Human genetic variation. Science 318 : 1842 1843.
58. Reilly KM, Loisel DA, Bronson RT, McLaughlin ME, Jacks T (2000) Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat Genet 26 : 109 113.
59. Reilly KM, Tuskan RG, Christy E, Loisel DA, Ledger J, Bronson RT et al (2004) Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects. Proc Natl Acad Sci USA 101 : 13008 13013.
60. Reilly KM, Broman KW, Bronson RT, Tsang S, Loisel DA, Christy ES et al (2006) An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model. Cancer Res 66 : 62 68.
61. Roberts A, Pardo-Manuel de Villena F, Wang W, McMillan L, Threadgill DW (2007) The polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems genetics. Mamm Genome 18 : 473 481.
62. Ruivenkamp CA, van Wezel T, Zanon C, Stassen AP, Vlcek C, Csikos T et al (2002) Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet 31 : 295 300.
63. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G et al (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409 : 928 933.
64. Schuz J, Jacobsen R, Olsen JH, Boice JD Jr., Johansen JK, McLaughlin C (2006) Cellular telephone use and cancer risk: update of a nationwide Danish cohort. J Natl Cancer Inst 98 : 1707 1713.
65. Schwartzbaum J, Ahlbom A, Malmer B, Lonn S, Brookes AJ, Doss H et al (2005) Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res 65 : 6459 6465.
66. Schwartzbaum JA, Ahlbom A, Lonn S, Malmer B, Wigertz A, Auvinen A et al (2007) An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol Biomarkers Prev 16 : 2448 2454.
67. Schwartzbaum JA, Ahlbom A, Lonn S, Warholm M, Rannug A, Auvinen A et al (2007) An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev 16 : 559 565.
68. Singer JB, Hill AE, Nadeau JH, Lander ES (2005) Mapping quantitative trait loci for anxiety in chromosome substitution strains of mice. Genetics 169 : 855 862.
69. Stemmer-Rachamimov AO, Louis DN, Nielsen GP, Antonescu CR, Borowsky AD, Bronson RT et al (2004) Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res 64 : 3718 3724.
70. Threadgill DW, Hunter KW, Williams RW (2002) Genetic dissection of complex and quantitative traits: from fantasy to reality via a community effort. Mamm Genome 13 : 175 178.
71. Trizna Z, de Andrade M, Kyritsis AP, Briggs K, Levin VA, Bruner JM et al (1998) Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas. Cancer Epidemiol Biomarkers Prev 7 : 553 555.
72. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG et al (2001) The sequence of the human genome. Science 291 : 1304 1351.
73. Vogel K, Klesse L, Velasco-Miguel S, Meyers K, Rushing E, Parada L (1999) Mouse tumor model for neurofibromatosis type 1. Science 286 : 2176 2179.
74. Wade CM, Kulbokas EJ 3rd., Kirby AW, Zody MC, Mullikin JC, Lander ES et al (2002) The mosaic structure of variation in the laboratory mouse genome. Nature 420 : 574 578.
75. Wang LE, Bondy ML, Shen H, El-Zein R, Aldape K, Cao Y et al (2004) Polymorphisms of DNA repair genes and risk of glioma. Cancer Res 64 : 5560 5563.
76. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P et al (2002) Initial sequencing and comparative analysis of the mouse genome. Nature 420 : 520 562.
77. Weiss WA, Burns MJ, Hackett C, Aldape K, Hill JR, Kuriyama H et al (2003) Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Res 63 : 1589 1595.
78. Wiemels JL, Wiencke JK, Kelsey KT, Moghadassi M, Rice T, Urayama KY et al (2007) Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev 16 : 1229 1235.
79. Wigertz A, Lonn S, Schwartzbaum J, Hall P, Auvinen A, Christensen HC et al (2007) Allergic conditions and brain tumor risk. Am J Epidemiol 166 : 941 950.
80. Xu G, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R et al (1990) The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63 : 835 841.
81. Xu G, O'Connell P, Viskochil D, Cawthorn R, Robertson M, Culver M et al (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62 : 599 608.
82. Youngren KK, Coveney D, Peng X, Bhattacharya C, Schmidt LS, Nickerson ML et al (2005) The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature 435 : 360 364.
83. Zhang S, Ramsay ES, Mock BA (1998) Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. Proc Natl Acad Sci USA 95 : 2429 2434.